The Assessment of Bone Mineral Density (BMD) and Fracture Risk after 3 Years of Adjuvant Zoledronic Acid in Postmenopausal (ER+) Early Breast Cancer
Eslamian, G., Harper-Wynne, C.Volume:
32
Journal:
Clinical Oncology
DOI:
10.1016/j.clon.2020.02.015
Date:
August, 2020
File:
PDF, 44 KB
2020